Conditions: Pancreas Transplantation Kidney Transplantation
Keywords: Simultaneous Pancreas-Kidney Transplantation mycophenolate GI problems
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 31

Brief summary:
Treatment with the immunosuppressive drug mycophenolate mofetil (MMF) may result in gastrointestinal (GI) complications in some patients. This study will assess if a switch from MMF to enteric-coated mycophenolate sodium (EC-MPS) results in improved GI and/or health-related quality of life outcomes and determine the proportion of pancreas-kidney transplant recipients who experience any GI complaints under MMF-based immunosuppressive treatment.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Enteric-coated mycophenolate sodium (EC-MPS)
Intervention descriptions: intervention 1: Experimental

Protocol document: